Results for tag: "Penthienate"

Pentosan polysulfate sodium (PPS) is a type of gastrointestinal drug used to treat a variety of conditions, including interstitial cystitis, bladder pain syndrome, and ulcerative colitis. It is a semi-synthetic compound derived from the cell walls of certain fungi, and is believed to work by reducing inflammation and restoring the protective mucus layer of the gastrointestinal tract. PPS is available in both oral and injectable forms, and is often used in combination with other medications. The pentosan polysulfate sodium market is a rapidly growing segment of the gastrointestinal drug market. It is driven by increasing prevalence of gastrointestinal diseases, rising awareness of the benefits of PPS, and the availability of generic versions of the drug. The market is expected to continue to grow in the coming years, as more patients seek out PPS as a treatment option. Some of the major companies in the pentosan polysulfate sodium market include Pfizer, Merck, Sanofi, Novartis, and Allergan. Show Less Read more